Gujarat Terce Laboratories Limited (BOM:524314)
53.00
+1.85 (3.62%)
At close: Jun 27, 2025
BOM:524314 Revenue
In the fiscal year ending March 31, 2025, Gujarat Terce Laboratories had annual revenue of 501.95M INR with 4.63% growth. Gujarat Terce Laboratories had revenue of 123.24M in the quarter ending March 31, 2025, with 0.96% growth.
Revenue
501.95M
Revenue Growth
+4.63%
P/S Ratio
0.76
Revenue / Employee
1.76M
Employees
286
Market Cap
382.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 501.95M | 22.21M | 4.63% |
Mar 31, 2024 | 479.75M | 11.92M | 2.55% |
Mar 31, 2023 | 467.83M | 66.49M | 16.57% |
Mar 31, 2022 | 401.34M | 149.56M | 59.40% |
Mar 31, 2021 | 251.78M | -123.66M | -32.94% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |